J. G. García Díaz

What to consider when pseudohypoparathyroidism is ruled out: iPPSD and differential diagnosis

B. Gener, E. Anda, R. Rodríguez-López, 2018, BMC Medical Genetics.

[Usefulness of Clinical Genetics in medical practice].

J. G. García Díaz, J. M. Mesa Latorre, 2012, Medicina clinica.

Novel therapeutics in hypertriglyceridaemia and chylomicronaemia

J. G. García Díaz, Juan de Dios García Díaz, 2020 .

Clinical utility of a combination of tumour markers in the diagnosis of malignant pleural effusions.

J. G. García Díaz, J. de Miguel, M. Gaspar, 2008, Anticancer research.

[Recurrent hemophagocytic syndrome and human immunodeficiency virus infection].

J. G. García Díaz, F. Alonso Navas, V. Guillén Camargo, 1988, Medicina clinica.

Long-term treatment persistence and maintained reduction of LDL-cholesterol levels with evolocumab over 30 months: Results from the Spanish cohort of the European prospective HEYMANS study

A. Caixàs, K. Ray, N. Dhalwani, 2023, Clínica e Investigación en Arteriosclerosis.

Novel therapeutics in hypertriglyceridaemia and chylomicronaemia.

J. G. García Díaz, 2020, Medicina clinica.

[Frequency and intraindividual variation of very low HDL cholesterol].

J. G. García Díaz, M. J. Gaspar Blázquez, José Miguel Hernández Rey, 2011, Medicina clinica.